Hansa Biopharma Ab
Clinical trials sponsored by Hansa Biopharma Ab, explained in plain language.
-
Breakthrough drug could give sensitized kids a second chance at kidney transplant
Disease control Recruiting nowThis study tests a drug called imlifidase in 10 highly sensitized children aged 1-17 who need a kidney transplant. These children have antibodies that make it hard to find a matching donor. The drug aims to quickly clear those antibodies so the transplant can happen. After the tr…
Phase: PHASE2 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 16, 2026 23:22 UTC
-
5-year follow-up checks if imlifidase helps kidney transplants last longer
Disease control Recruiting nowThis study follows 150 people who received imlifidase before a kidney transplant to see how long their new kidney works. Researchers will check for graft failure (return to dialysis, re-transplant, or kidney removal) over 5 years. A separate group of similar patients not receivin…
Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC